Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract

被引:47
作者
Chang, JG
Chen, YJ
Perng, LI
Wang, NM
Kao, MC
Yang, TY
Chang, CP
Tsai, CH
机构
[1] China Med Coll Hosp, Dept Med Res, Div Mol Med, Taichung, Taiwan
[2] Mackay Mem Hosp, Dept Med Res, Div Mol Med, Taipei, Taiwan
[3] Taipei Municipal Jen Ai Hosp, Dept Mol Med, Taipei, Taiwan
[4] Taipei Municipal Jen Ai Hosp, Dept Surg, Taipei, Taiwan
关键词
mutation analysis; PTEN/MMAC1; digestive tract cancer; aberrant transcript;
D O I
10.1016/S0959-8049(98)00411-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The 10q23.3 gene PTEN (phosphatase and Tensin homologue deleted on chromosome 10) or MMAC1 (mutated in multiple advanced cancers 1) was recently reported to undergo frequent mutation, including mutations and deletions in multiple advanced cancers. This study showed that the aberrant transcripts of this gene are frequently found in cancers of the digestive tract, paired non-cancerous tissues and normal peripheral mononuclear cells. Sequence analysis of the aberrant transcripts revealed three types of deletions: (i) a deletion junction with a splicing-like donor or acceptor sequence; (ii) several-base homology near or between the donor acceptor site at the deletion junction; and (iii) deletion with insertion. From these results, it is suggested that aberrant transcripts of PTEN/MMAC1 found by nested reverse transcription-polymerase chain reaction are a common (or natural) phenomenon unrelated to oncogenesis. The mechanism producing these aberrant transcripts needs further investigation. Using single-strand conformation polymorphism and direct sequencing to analyse for small base changes of the genomic DNA of the PTEN/MMAC1 gene revealed no point mutations or small base changes. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 26 条
  • [1] Boström J, 1998, CANCER RES, V58, P29
  • [2] Cairns P, 1997, CANCER RES, V57, P4997
  • [3] CHANG JG, 1995, AM J HUM GENET, V57, P1503
  • [4] Chen YJ, 1997, INT J CANCER, V71, P350, DOI 10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO
  • [5] 2-X
  • [6] CHEN YJ, 1997, INT J CANCER, V72, P355
  • [7] Dahia PLM, 1997, CANCER RES, V57, P4710
  • [8] LOSS OF HETEROZYGOSITY IN LIVER-TUMORS
    DING, SF
    HABIB, NA
    [J]. JOURNAL OF HEPATOLOGY, 1995, 22 (02): : 230 - 238
  • [9] Guldberg P, 1997, CANCER RES, V57, P3660
  • [10] HERBST RA, 1994, CANCER RES, V54, P3111